英文別名 Vinorelbine bitartrate; 3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt; Navelbine tartrate; Nvb; Navelbine; Vinorelbin; Bitartrate; Vinorelbine ditartaric acid; Vinorelbine ditartrate salt; Butanedioate(1:2); C'-norvincaleukoblastine,3',4'-didehydro-4'-dioxy-,(R-(R*,R*))-2,3-dihydroxy; 5'-noranhydrovinoblastine tartrate; 3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine; [R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt]; Pacilitaxel; Vinorelbineditartrate salt hydrate; Vinorelbine tartrate usp standard; Vinorelbine tartrate; Vinorelbine bitratrate; Vinorelbine tartarate; methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2); methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2); methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate.
關(guān)鍵字： 長春瑞賓雙酒石酸鹽;長春瑞濱;長春瑞濱酒石酸酯(鹽);酒石酸長春瑞濱生產(chǎn)廠家;酒石酸長春瑞濱價(jià)格;
湖北邁科醫(yī)藥科技有限公司作為全球?qū)I(yè)的服務(wù)型醫(yī)藥貿(mào)易企業(yè)之一，公司凝聚了一支高素質(zhì)、具有國際化視野的經(jīng)營管理團(tuán)隊(duì)，并依托在藥證法規(guī)、商業(yè)模式、研發(fā)技術(shù)、綜合管理等方面的優(yōu)勢(shì)，在業(yè)內(nèi)樹立了良好口碑，已成為全球眾多上市藥企的醫(yī)藥定制研發(fā)生產(chǎn)服務(wù)合作伙伴。